Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma. - Wikidata - awgldk - TriplyDB

Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma.

Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma.

http://www.wikidata.org/entity/Q34680693

about

MYC Deregulation in Primary Human Cancers.UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses.SDHB-related pheochromocytoma and paraganglioma penetrance and genotype-phenotype correlations.Evaluation of somatostatin, CXCR4 chemokine and endothelin A receptor expression in a large set of paragangliomas.Programmed cell death ligands expression in phaeochromocytomas and paragangliomas: Relationship with the hypoxic response, immune evasion and malignant behavior.TumorFusions: an integrative resource for cancer-associated transcript fusions.Extent of surgery for phaeochromocytomas in the genomic era.The role of metabolic enzymes in mesenchymal tumors and tumor syndromes: genetics, pathology, and molecular mechanisms.The clinical genetics of phaeochromocytoma and paraganglioma.New Perspectives on Pheochromocytoma and Paraganglioma: Toward a Molecular Classification.Emerging Opportunities for Target Discovery in Rare Cancers.Activating FGFR1 Mutations in Sporadic Pheochromocytomas.Predictors of outcome in phaeochromocytomas and paragangliomas.High resolution tissue mass spectrometry imaging reveals a refined functional anatomy of the human adult adrenal gland.Annual review issue: An overview of 50 years of progress in endocrine pathology.No reason to reconsider HIF-2 as an oncogene in neuroblastoma and other cancer forms.Metabolic implications of hypoxia and pseudohypoxia in pheochromocytoma and paraganglioma.Genomic Landscape of Pheochromocytoma and Paraganglioma.New Insights into the Nuclear Imaging Phenotypes of Cluster 1 Pheochromocytoma and Paraganglioma.Genetic analysis of 779 advanced differentiated and anaplastic thyroid cancers.Current diagnostic imaging of pheochromocytomas and implications for therapeutic strategy.Exome analysis of carotid body tumor.Co-Occurrence of Pheochromocytoma-Paraganglioma and Cyanotic Congenital Heart Disease: A Case Report and Literature Review.A Clinical Roadmap to Investigate the Genetic Basis of Pediatric Pheochromocytoma: Which Genes Should Physicians Think About?Alternative assembly of respiratory complex II connects energy stress to metabolic checkpoints.Pheochromocytoma and Paraganglioma in Neurofibromatosis type 1: frequent surgeries and cardiovascular crises indicate the need for screening.Pathogenicity and Penetrance of Germline SDHA Variants in Pheochromocytoma and Paraganglioma (PPGL).Mathematical modeling of disease dynamics in SDHB- and SDHD-related paraganglioma: Further step in understanding hereditary tumor differences and future therapeutic strategies Advances in adrenal tumors 2018 BAP1 links metabolic regulation of ferroptosis to tumour suppression Exome-wide analysis of bi-allelic alterations identifies a Lynch phenotype in The Cancer Genome Atlas The Diagnosis and Clinical Significance of Paragangliomas in Unusual Locations Germline SDHB and SDHD mutations in pheochromocytoma and paraganglioma patients New insights on the pathogenesis of paraganglioma and pheochromocytoma Oncometabolite induced primary cilia loss in pheochromocytoma Hypoxia Signaling and Circadian Disruption in and by Pheochromocytoma Modified SureSelect Target Enrichment Protocol for Illumina Multiplexed Sequencing of FFPE Samples Whole Exome Sequencing Uncovers Germline Variants of Cancer-Related Genes in Sporadic Pheochromocytoma

P2860

Q33836755-B96FF61D-CB18-4548-BE63-E63E92A54BAF Q38667837-2B87081C-BC5C-4EA7-871F-2AF3B313A793 Q38857083-EA7A7E65-655E-4584-85C8-05EB1A5204C0 Q47108225-937DF888-6DBD-4144-93FC-6525A56EB04A Q47181092-B41DB76F-171B-43AF-B910-3D98E6C957B7 Q47207132-7468E21F-2DDE-4FD7-90EE-C6150FC07464 Q47552587-4A3BF8F2-E778-4801-8B22-8C5424BACBC7 Q47728815-C953D18E-74A3-4437-A791-10582CF92017 Q47823095-64FEA608-2663-477F-AAF8-172E20743C41 Q47934716-E4339DC7-076E-486A-B025-609BE716C6E3 Q47941750-20BC7F8B-7466-4ECF-BD5A-C5EA966A8DAC Q47959074-0379681B-238A-4192-BAFA-B5B31FE27ABA Q48246997-66D10C73-0218-48F2-BFCA-5DA1AD56D579 Q49552997-35881249-0C0A-49ED-9620-9A18FFF36BCB Q49852329-73712A7B-EC80-4B09-8A9C-21285FDBB70A Q49886828-504B06AE-80F7-4218-A6D5-CA2947604770 Q49948832-5ACC4E9B-1015-4696-AFE0-E98CA8F4B1AF Q50138577-B5678E8D-6292-41CA-BBA5-6BB88E0C0F51 Q50229413-7CB5F8F2-1AE0-42A9-A106-3ED9B6AC0C78 Q52609129-AE2737A5-E90E-47F6-825E-8EFCC9C153C2 Q52653093-50D666B0-E051-4D27-8750-B32A20DB662F Q52674249-E133D880-0C86-4980-A5D9-DBCA9540AC9E Q53826779-4138633F-195F-472B-A586-B107A8B15536 Q55263855-2B63FED1-F94B-4A2E-8F67-174300A2416D Q55265387-9152713C-FD02-4D7B-A1E2-A8B2A77629DD Q55446242-04916E24-2B49-4BBE-A863-6A8A38EAC687 Q55518665-6B17C89C-8754-4FDA-A3C2-E18CC34E03A2 Q57169543-46F13615-FCFF-4989-AE15-92C3141EC031 Q57177998-D4F16135-73A4-4808-807B-6A97E2C23C46 Q57246269-77408977-0A52-4512-862C-45C803AECF2A Q57646224-5A18CF64-E43F-43EB-868C-A965A1FDF21F Q57793471-C768333B-703D-45EB-9560-CAEB6C7C0A70 Q57818904-CBBA228C-8EA0-4922-8451-C15B487147AE Q57821959-1B45BE54-E64E-40A6-AA4D-0DCF534A7458 Q57822415-3337CF9F-1CFC-4A81-AFA2-CA754A286ABA Q58553604-E25EA44D-D42C-4778-973C-EDC3171F597D Q58569259-AB1529E8-A39D-4587-AFD3-46DE3D361553 Q58766079-CD18B7AA-DD74-4DB7-8014-93F3CAA886B0

P2860

Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma.

http://www.wikidata.org/entity/Q34680693

description

2017 nî lūn-bûn

@nan

2017 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma.

@ast

Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma.

@en

Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma.

@nl

type

label

Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma.

@ast

Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma.

@en

Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma.

@nl

prefLabel

Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma.

@ast

Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma.

@en

Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma.

@nl

P1433

Q34680693-3D2C5AEC-C708-4B67-9219-707087FA5A13

P1476

Q34680693-BFAA0242-A1CD-42A1-AC0E-E71DD117565C

P2093

Q34680693-0132FBA4-102C-470C-97FC-B61F0AD92177

Q34680693-0F424F8F-C1A8-4990-B748-89A4437DA3DD

Q34680693-1525B81D-1322-448C-ABFE-A6901823FA56

Q34680693-18F00983-4707-4AAC-B4C6-1A6DBBBB7A03

Q34680693-3825884F-A806-4EC7-BBBB-5DA3921A7E69

Q34680693-4B787B82-62FE-4235-AA68-30EDD5139361

Q34680693-59B95C14-75A6-4E11-996C-710B078C2097

Q34680693-7AF3C35B-0125-4048-8D25-49C8BADFD88B

Q34680693-7E1343AD-D3D4-4C3D-8990-95DA0F45D3D1

Q34680693-83FB862E-B720-47F5-92B2-0520C6CB44F4

P2860

Q34680693-0FDB8643-8D5A-43ED-9ECC-04A267D0290A

Q34680693-364AB526-428D-495E-856E-A8E6EC12FC2B

Q34680693-39022940-13E1-4839-BF71-5A8D2DCCD47E

Q34680693-422C34F4-4B1B-4EA2-B35E-D9A6BB1A7097

Q34680693-459B48F2-1E50-4937-A608-78EFA6CFEC8F

Q34680693-46AA84BA-527A-4D81-ADF2-5DB9CE8CAD4E

Q34680693-4723DB9E-E636-45E5-A0AA-FD031AC5E67F

Q34680693-540981E1-776E-4BEB-87F3-C9E87C51CE2E

Q34680693-57F62403-E699-43DC-A813-AE4DA054DB59

Q34680693-629FA2C0-D992-4D15-BEE1-EFCFFDCDCB70

P304

Q34680693-439BF7C4-4538-443A-84D8-DCD34A1973A7

P31

Q34680693-38D2B476-8E46-42EA-842F-104554F09B69

P356

Q34680693-E8C94B4E-8EEF-4B25-86CB-E71253CE6EDB

P433

Q34680693-5AE55E0D-2967-47A2-AB6B-367C71ABCF5C

P478

Q34680693-D7FD8AE6-1F96-41AB-A1BE-239B72E0E6E0

P50

Q34680693-5616B875-16D2-4DB2-A38D-C2925081B46F

Q34680693-78ABFA0D-8D48-478D-99F4-99CDB17CAC55

Q34680693-9D51D5E0-B6DA-4341-A05B-D5CF803E1359

Q34680693-B8AD9A72-A7A1-4255-BCA2-B17A70A8840B

Q34680693-BDA1D104-6DC3-4201-BE0C-D502D0582C77

Q34680693-C3D88E14-99E4-4353-9C4F-45189AAB152D

Q34680693-D68EC3F8-C4A7-4CB3-852F-28B7DFD28BC1

P577

Q34680693-75527175-132B-406F-90EF-0872BEBD45AE

P698

Q34680693-862DA07A-2467-43EF-B95D-3BCF59D085F1

P921

Q34680693-88D52498-6DB5-49F1-8CFE-528B072FD334

P932

Q34680693-CE2CC919-D0AF-4624-BC53-91B82E90BD82

P356

J.CCELL.2017.01.001

P1433

P1476

Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma.

@en

P2093

A Gordon Robertson

http://www.w3.org/2001/XMLSchema#string

Aguirre A de Cubas

http://www.w3.org/2001/XMLSchema#string

Amy R Johnson

http://www.w3.org/2001/XMLSchema#string

Antonio L Amelio

http://www.w3.org/2001/XMLSchema#string

Arthur S Tischler

http://www.w3.org/2001/XMLSchema#string

Bradley A Murray

http://www.w3.org/2001/XMLSchema#string

Brandon Wenz

http://www.w3.org/2001/XMLSchema#string

Esther Korpershoek

http://www.w3.org/2001/XMLSchema#string

Hans K Ghayee

http://www.w3.org/2001/XMLSchema#string

Lauren Fishbein

http://www.w3.org/2001/XMLSchema#string

P2860

Mutational heterogeneity in cancer and the search for new cancer-associated genes

Somatic HIF2A gain-of-function mutations in paraganglioma with polycythemia

Hypoxia-inducible mir-210 regulates normoxic gene expression involved in tumor initiation.

A HIF1alpha regulatory loop links hypoxia and mitochondrial signals in pheochromocytomas

Altered Notch signaling resulting from expression of a WAMTP1-MAML2 gene fusion in mucoepidermoid carcinomas and benign Warthin's tumors

The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data

Eukaryotic cold shock domain proteins: highly versatile regulators of gene expression.

ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking

Integrated RNA and DNA sequencing improves mutation detection in low purity tumors.

CRTC1/MAML2 gain-of-function interactions with MYC create a gene signature predictive of cancers with CREB-MYC involvement.

P304

181-193

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CCELL.2017.01.001

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P50

Katherine L Nathanson

Ignaty Leshchiner

Anne-Paule Gimenez-Roqueplo

Cancer Genome Atlas Research Network

P577

2017-02-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28162975

http://www.w3.org/2001/XMLSchema#string

P921

phaeochromocytoma

P932

5643159

http://www.w3.org/2001/XMLSchema#string